Search - tctmd.com

Displaying 241 - 260 of 306

Sort: Relevancy | Date

Presentation Cell Therapy 2014

Stem Cell & SDF-1/CXCR4 In Diabetes

Presenter: Feng Dong

January 21, 2014

Presentation TCT 2013

Pro Position: FREEDOM was the Final Nail in the Coffin!

Presenter: Duane Pinto

October 31, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

The Glucometabolic Milieu: Implications on Platelet Function in the PCI Patient

Presenter: Frederick Feit

October 30, 2013

Presentation TCT 2013

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Presenter: Marco Wainstein

October 30, 2013

Presentation TCT 2013

Incretin-Based Therapy: Emerging Evidence for a Better Path to Glycemic Control

Presenter: Michael Farkouh

October 30, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Presenter: Kevin Beatt

October 30, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: CABG for All!

Presenter: Craig Smith

October 30, 2013

Presentation TCT 2013

Concluding Case: A 62 year Old diabetic Patient with STEMI

Presenter: Vladimir Dzavik

October 30, 2013

Presentation TCT 2013

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

Presenter: Vasim Farooq

October 30, 2013

Presentation TCT 2013

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak

Presenter: David Taggart

October 29, 2013

Presentation TCT 2013

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Life Is Not So Simple! It Is the Anatomy Not the Diabetes Per Se

Presenter: Gregg Stone

October 29, 2013

Presentation TCT 2013

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Presenter: Elvin Kedhi

October 29, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Presenter: Antonio Colombo

October 29, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

FREEDOM: Essential results

Presenter: Michael Farkouh

October 27, 2013

Presentation

Quality of Life after PCI vs. CABG Among Patients with Diabetes and Multivessel CAD

Presenter: M.S. Abdallah

October 15, 2013

Presentation

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

Presenter: Yaling Han

October 09, 2013

Presentation

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Presenter: M. Leoncini

October 09, 2013

Advertisement

Stem Cell & SDF-1/CXCR4 In Diabetes

Pro Position: FREEDOM was the Final Nail in the Coffin!

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

The Glucometabolic Milieu: Implications on Platelet Function in the PCI Patient

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Incretin-Based Therapy: Emerging Evidence for a Better Path to Glycemic Control

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Diabetes Mellitus and Multivessel Disease: CABG for All!

Concluding Case: A 62 year Old diabetic Patient with STEMI

Clinical and Angiographic Risk Stratification (from BARI 2D to FREEDOM) Influence on Treatment Outcomes

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Of Course! Thank You for the FREEDOM to Speak

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Life Is Not So Simple! It Is the Anatomy Not the Diabetes Per Se

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

FREEDOM: Essential results

Quality of Life after PCI vs. CABG Among Patients with Diabetes and Multivessel CAD

Short-term Rosuvastatin for Prevention of Contrast-Induced Acute Kidney Injury (CI-AKI) in Patients with Diabetes and Chronic Kidney Disease

PRATO-ACS: Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content